Predictmedix Inc. (CSE:PMED, OTCQB:PMEDF) has announced its accuracy rates for identifying respiration rate, heart rate, and core body temperature as part of its Fit for Work screening solutions for industries across the globe, which it says validated its technology on 270 participants including two clinical sites.
The artificial intelligence company said the “exceptional” results of the accuracy rates were as follows: identification of respiration rate was 98.38%; identification of core body temperature was 98.37%; and identification of heart rate was 85%.
“The results of the study brings not only us, but also our current clients and potential clients in our pipeline the confidence that our Fit for Work screening solutions will be a game changer for workplaces across many industries around the world,” Predictmedix interim CEO Dr Rahul Kushwah said in a statement.
READ: Predictmedix announces US$1.4M letter of intent for 80 Safe Entry Stations from KaTron Defence Space and Simulation Technologies
“The presence of infectious disease, impairment, and extreme fatigue results in changes of physiological parameters which our technology can identify with high accuracy,” Kushwah added.
Predictmedix noted that it has initiated the next phase of Third-Party Validation by creating manuscripts, which will be sent for peer review to academic journals for publication.
The company added that it has also made significant developments to its novel intellectual property (IP) for the filing of its patents.
Predictmedix is an artificial intelligence company developing disruptive tools for impairment testing and health care aimed at use across various workplaces and by law enforcement agents.
Contact Sean at sean@proactiveinvestors.com